Manufacturer record
Seeko biotics: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Seeko biotics was declared Not of Standard Quality in December 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PMC-2311, Pregabalin SR 75 and Methylcobalamin 1500 mcg Tablets (exp Aug 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Pregabalin and Methylcobalamin, Dissolution of Pregabalin and Description. Listed in the December 2023 alert.
Records by type
1 record linked to Seeko biotics in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pregabalin SR 75 and Methylcobalamin 1500 mcg Tablets | Batch PMC-2311Mfg Sep 2023 · Exp Aug 2025 | Assay of Pregabalin and Methylcobalamin, Dissolution of Pregabalin and DescriptionAssay | CDL KolkataCDSCO lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.